International Journal of Radiation Oncology*Biology*Physics
Volume 37, Issue 2, 15 January 1997, Pages 259-267
Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials
References (46)
- et al.
Accelerated vs. conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumor proliferation
Radiother. Oncol.
(1992) - et al.
Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation—126 fractions applied within 6 weeks
Int. J. Radiat. Oncol. Biol. Phys.
(1989) - et al.
Clinical radiobiology of malignant melanoma
Radiother. Oncol.
(1989) - et al.
Controlled clin
Trials
(1981) - et al.
Twice a day vs. once a day radiation therapy in head and neck cancer (Abstr.)
Int. J. Radiat. Oncol. Biol. Phys.
(1989) - et al.
Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma
Int. J. Radiat. Oncol. Biol. Phys.
(1989) - et al.
Irradiation therapy with multiple small fractions per day in urinary bladder cancer
Radiother. Oncol.
(1985) - et al.
Misonidazole combined with hyperfractionation in the management of malignant glioma
Int. J. Radiat. Oncol. Biol. Phys.
(1984) - et al.
Kinetics of recovery from sublethal radiation damage in four murine tumors
Radiother. Oncol.
(1990) - et al.
Hyperfractionation vs. conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
Radiother. Oncol.
(1992)
Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: preliminary report by the Radiation Therapy Oncology Group (RTOG)
Int. J. Radiat. Oncol. Biol. Phys.
(1987)
Dose intensification in curative head and neck cancer radiotherapy—Linear quadratic analysis and preliminary assessment of clinical results
Int. J. Radiat. Oncol. Biol. Phys.
(1993)
Prospective randomized trial comparing hyperfractionated vs. conventional radiotherapy in stages III and IV oropharyngeal carcinoma
Int. J. Radiat. Oncol. Biol. Phys.
(1991)
Fractionation sensitivity ( ratio) of human melanoma xenografts
Radiother. Oncol.
(1994)
Single fraction per day vs. two fractions per day vs. radiochemotherapy in the treatment of head and neck cancer
Int. J. Radiat. Oncol. Biol. Phys.
(1990)
Fraction size in external beam radiation therapy in the treatment of melanoma
Int. J. Radiat. Oncol. Biol. Phys.
(1991)
RTOG 88-08 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable nonsmall-cell lung cancer with minimum three year follow-up (Abstr.)
Int. J. Radiat. Oncol. Biol.
(1995)
Heterogeneity in the fractionation sensitivities of human tumor cell lines: Studies in a three-dimensional model system
Int. J. Radiat. Oncol. Biol. Phys.
(1995)
Time-dose factors in radiotherapy: A review of the human data
Radiother. Oncol.
(1990)
Changes in early and late radiation responses with altered dose fractionation: Implications for μ dose-survival relationships
Int. J. Radiat. Oncol. Biol. Phys.
(1982)
Characteristics of dose-response relationships for late radiation effects: An analysis of skin telangiectasia and of head and neck morbidity
Radiother. Oncol.
(1991)
Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer
Int. J. Radiat. Oncol. Biol. Phys.
(1986)
A review of ratios for experimental tumors: Implications for clinical studies of altered fractionation
Int. J. Radiat. Oncol. Biol. Phys.
(1985)
Cited by (135)
Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
2012, Clinical Neurology and NeurosurgeryCitation Excerpt :This observation is in accordance with the current literature in terms of a “maximal safe resection” [8,10,21]. The role of radiotherapy in the treatment of glioblastoma is unchallenged [15]. As expected, we saw significant prognostic implication of external beam radiation with a total dose of at least 54 Gy.
Issues in Translating Imaging Technology and Presurgical Diffusion Tensor Imaging
2023, Functional Neuroradiology: Principles and Clinical ApplicationsImproving control of high-grade glioma by ultra-hyper-fractionated radiotherapy
2022, Journal of Neuroscience ResearchBladder-Sparing Approaches to Treatment of Muscle-Invasive Bladder Cancer
2022, Urologic Oncology: Multidisciplinary Care for PatientsUltra-hyper-fractionated radiotherapy for high-grade gliomas
2021, Journal of Neuroscience Research
Copyright © 1997 Published by Elsevier Inc.